Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction

This publication has 11 references indexed in Scilit:

• Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes
  Circulation, 2002
• Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction
  New England Journal of Medicine, 2002
• Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction
  Journal of the American College of Cardiology, 2002
• The Pharmacodynamics of Parenteral Glycoprotein IIb/IIIa Inhibitors
  Journal of Interventional Cardiology, 2002
• Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction
  New England Journal of Medicine, 2001
• Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial
  The Lancet, 2001
• Reperfusion revisited: Beyond TIMI3 flow
  Clinical Cardiology, 1999
• Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty: Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot study
  Journal of the American College of Cardiology, 1999
• Effect of Glycoprotein IIb/IIIa Receptor Blockade on Recovery of Coronary Flow and Left Ventricular Function After the Placement of Coronary-Artery Stents in Acute Myocardial Infarction
  Circulation, 1998
• Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarction
  Journal of the American College of Cardiology, 1994